ad image

DURECT

1 / 1
How is an increased focus on patient-centric concerns influencing the way that you work?
Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

PAO-07-23-RT-02Jul 21, 2023
DURECT Corporation
FDA

DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII

DURECT Corporation

PR-M08-18-NI-059Aug 15, 2018
DURECT Corporation
Licensing Agreement

DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR® (SABER®-Bupivacaine)

DURECT Corporation

PR-M05-18-NI-042May 10, 2018
1 / 1